Compare Abeona Therapeutics Inc (ABEO) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs TeraWulf Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while TeraWulf Inc trades at $17.41 (market cap $8.35B). The key difference: TeraWulf Inc is far larger — about 19.8× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, TeraWulf Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | WULF | |
|---|---|---|
Market Cap | $421.19M | $8.35B |
Sector | Health | Technology |
52-Week High | $7.45 | $28.98 |
52-Week Low | $4.17 | $5.24 |
Enterprise Value | $276.10M | $10.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
